| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |